- Nachrichtendetail
-
03.07.2024 14:04:13 - dpa-AFX: *J&J : HEALTH CANADA AUTHORIZES RYBREVANT COMBINATION FOR EGFR EXON 20 NON-SMALL CELL LUNG CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 145,740 | 23.08.24 18:26:54 | +0,900 | +0,62% | 145,340 | 145,640 | 146,080 | 144,840 |
